Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension | NCT00693199 | Trialant
CompletedInterventionalNot ApplicableUpdated Aug 8, 2008
Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension
ClinicalTrials.gov ID
NCT00693199
Lead Sponsor
Anhui Medical UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
360Actual
Last Update Posted
Aug 8, 2008Estimated
Start Date
Jul 2006
Primary Completion Date
Oct 2006Actual
Completion Date
Oct 2006Actual
Brief Summary
The aim of this study was to investigate the efficacy and safety of low dose amlodipine alone, or combined with low dose terazosin in male patients with both lower urinary tract symptoms and hypertension.
Lower Urinary Tract Symptoms
Hypertension
amlodipine
terazosin
amlodipine plus terazosin
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
Male
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Men 50 years or older
with LUTS [defined as International Prostate Symptom Score (IPSS) >= 10].
Stage 1 or 2 essential hypertension (SBP >= 140 mm Hg and < 180 mm Hg and/or DBP >= 90 mm Hg and < 110 mm Hg)
Exclusion Criteria:
A history of postural hypotension
Secondary hypertension
Prostate cancer
Prostate surgery or other intervention
Use of any agents to influence the LUTS symptoms in the last 4 weeks
Other severe diseases
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Parallel Assignment
Masking
Quadruple
No central contacts
There are no central contacts for this study.
Biomedicine Inistitute of Anhui Medical University
Hefei, Anhui 230032, China
Lead Sponsor
Anhui Medical UniversityOTHER
Collaborators
The University of Science and Technology of ChinaOTHER